Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volume.
Andrew F ScarsbrookGillian WardPatrick MurrayRebecca GoodyKaren MarshallGarry McDermottRobin PrestwichGanesh RadhakrishnaPublished in: BMC cancer (2017)
ClinicalTrials.gov Identifier - NCT02285660 (Registered 21/10/2014).